The Rheumatology Podcast

Dr James Galloway and Dr Justin Mason, Imperial College London, UK discuss a paper published in the Journal by John Stone et al. who looked at patients with IgG4 related disease treated with rituximab, to determine if there were potential markers to predict relapse in patients after treatment. They discuss the potential implications for future treatment, drawbacks of the study and possible future research directions for the disease.

Dr James Galloway and Dr Louise Hamilton, Norfolk and Norwich University Hospital, UK discuss the key findings of the updated BSR guidelines on axial spondyloarthritis and recommendations for treatment. They highlight the importance of considering extra-articular manifestations in treatment and the possibility of switching treatment if anti-TNF treatment fails.

Dr James Galloway and Dr Louise Hamilton, Norfolk and Norwich University Hospital, UK discuss the key findings of the updated BSR guidelines on axial spondyloarthritis and recommendations for treatment. They highlight the importance of considering extra-articular manifestations in treatment and the possibility of switching treatment if anti-TNF treatment fails.

Dr Marwan Bukhari and Prof Christopher Denton, University College London, London, UK, discuss the new BSR and BHPR guidelines for the management of scleroderma and systemic sclerosis. They discuss the key recommendations of these guidelines and the importance of proper patient assessment to provide the correct management for each affected individual.

Dr Marwan Bukhari and Prof Christopher Denton, University College London, London, UK, discuss the new BSR and BHPR guidelines for the management of scleroderma and systemic sclerosis. They discuss the key recommendations of these guidelines and the importance of proper patient assessment to provide the correct management for each affected individual.

Dr Marwan Bukhari and Prof Christopher Denton, University College London, London, UK, discuss the new BSR and BHPR guidelines for the management of scleroderma and systemic sclerosis. They discuss the key recommendations of these guidelines and the importance of proper patient assessment to provide the correct management for each affected individual.

Dr Marwan Bukhari and Dr Ian Giles (University College London Hospital, UK) discuss the treatment of rheumatic problems in relation to pregnancy and the BSR and BHPR guideline on prescribing drugs during pregnancy. They discuss the key findings an

Dr Marwan Bukhari and Dr Ian Giles (University College London Hospital, UK) discuss the treatment of rheumatic problems in relation to pregnancy and the BSR and BHPR guideline on prescribing drugs during pregnancy. They discuss the key findings an

Prof Jaap van Laar, Editor of Rheumatology and Dr Eric Matteson, Mayo Clinic, Rochester, USA discuss the study about the level of dosing of corticosteroids in giant cell arthritis in their retrospective cohort study over a 15-year period. They tal